Research Analysts’ New Coverage for July 28th (BBNX, BDX, COO, EW, FTH, GKOS, GXO, HRB, IART, MMED)

Research Analysts’ new coverage for Tuesday, July 28th:

UBS Group AG initiated coverage on shares of Beta Bionics (NASDAQ:BBNX). The firm issued a buy rating and a $22.00 price target on the stock.

UBS Group AG began coverage on shares of Becton, Dickinson and Company (NYSE:BDX). UBS Group AG issued a buy rating on the stock.

UBS Group AG initiated coverage on shares of Cooper Companies (NASDAQ:COO). They issued a neutral rating and a $75.00 target price on the stock.

UBS Group AG assumed coverage on shares of Edwards Lifesciences (NYSE:EW). UBS Group AG issued a buy rating and a $110.00 target price on the stock.

Oppenheimer Holdings, Inc. initiated coverage on shares of Sensei Biotherapeutics (NASDAQ:FTH). The firm issued an outperform rating and a $60.00 target price on the stock.

UBS Group AG began coverage on shares of Glaukos (NYSE:GKOS). UBS Group AG issued a neutral rating on the stock.

Wells Fargo & Company initiated coverage on shares of GXO Logistics (NYSE:GXO). They issued an overweight rating and a $18.00 target price on the stock.

Stephens initiated coverage on shares of H&R Block (NYSE:HRB). Stephens issued an equal weight rating and a $47.00 target price on the stock.

UBS Group AG initiated coverage on shares of Integra LifeSciences (NASDAQ:IART). UBS Group AG issued a neutral rating and a $19.00 price target on the stock.

UBS Group AG started coverage on shares of MiniMed Group (NASDAQ:MMED). The firm issued a buy rating and a $25.00 target price on the stock.

William Blair assumed coverage on shares of Rapport Therapeutics (NASDAQ:RAPP). The firm issued an outperform rating on the stock.

UBS Group AG assumed coverage on shares of Sight Sciences (NASDAQ:SGHT). The firm issued a buy rating and a $7.00 target price on the stock.

UBS Group AG assumed coverage on shares of Shoulder Innovations (NYSE:SI). UBS Group AG issued a buy rating and a $27.00 price target on the stock.

UBS Group AG assumed coverage on shares of STAAR Surgical (NASDAQ:STAA). The firm issued a sell rating and a $20.00 target price on the stock.

Canaccord Genuity Group Inc. initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX). The firm issued a buy rating and a $35.00 target price on the stock.

UBS Group AG initiated coverage on shares of TransMedics Group (NASDAQ:TMDX). They issued a neutral rating and a $80.00 price target on the stock.

UBS Group AG started coverage on shares of Tandem Diabetes Care (NASDAQ:TNDM). The firm issued a neutral rating and a $18.00 price target on the stock.